Dr. Higgins on management of post-Aquablation blood loss
“From our standpoint, bigger prostates bleed more…From that, we started taking a different approach for those larger prostates,” says Andrew Higgins, MD.
In this video, Andrew Higgins, MD, discusses the background and findings of the study, “Prostate Aquablation: 2 years of perioperative outcomes,” presented recently at the 2021 American Urological Association annual meeting.
In the study, Higgins and coauthors implemented electrocautery protocols to mitigate blood loss among patients undergoing Aquablation.
Higgins is a urology resident at Einstein Healthcare Network, Philadelphia, Pennsylvania.
Academic, private practice urologists collaborate to change BPH reimbursement
April 1st 2024"We really aimed to affect 3 different contraindications and instead achieved retirement of the entire policy, which, we think, really opens up this wonderful technology to literally hundreds of thousands more patients across the country," says Arpeet Shah, MD.
Lenvatinib/pembrolizumab compares favorably with frontline standards in renal cell carcinoma
February 2nd 2024“Combination therapy with lenvatinib plus pembrolizumab provides a comparable OS, and a trend of improvement in PFS and response outcomes, compared with most current global SOC therapies for treatment-naïve patients with advanced renal cell carcinoma,” the study authors wrote.
